LYMPH LIGHT

GOAL

Evaluation of the efficacy of photobiomodulation (PBM) therapy ​in the management of breast cancer-related lymphedema.

STUDY DESIGN

Prospective, randomized, crossover trial with breast cancer patients who get diagnosed with lymphedema after they completed their breast cancer treatment. The study is recruiting patients at the Jessa Hospital since January 2021 until present (NCT04690439).

Group A (n=52)	PBM group (n=52)
9 weeks: Manual lymphatic drainage + PBM (2x/week) 9 weeks:  Manual lymphatic drainage (2x/week)	9 weeks: Manual lymphatic drainage (2x/week) 9 weeks:  Manual lymphatic drainage  + PBM (2x/week) ​

STUDY RESULTS

No preliminary results are available. 

PUBLICATIONS

 

PARTNERS